Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 70

1.

A Model-Based Economic Evaluation of Biologic and Non-Biologic Options for the Treatment of Adults with Moderately-to-Severely Active Ulcerative Colitis after the Failure of Conventional Therapy.

Tappenden P, Ren S, Archer R, Harvey R, James MM, Basarir H, Stevens J, Lobo A, Hoque S.

Pharmacoeconomics. 2016 Apr 28. [Epub ahead of print]

PMID:
27125898
2.

The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis.

Kaltenthaler E, Carroll C, Hill-McManus D, Scope A, Holmes M, Rice S, Rose M, Tappenden P, Woolacott N.

Health Technol Assess. 2016 Apr;20(26):1-48. doi: 10.3310/hta20260.

3.

Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective.

Thokala P, Simpson EL, Tappenden P, Stevens JW, Dickinson K, Ryder S, Harrison P.

Pharmacoeconomics. 2016 Feb 18. [Epub ahead of print]

PMID:
26892974
4.

Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review.

Essat M, Harnan S, Gomersall T, Tappenden P, Wong R, Pavord I, Lawson R, Everard ML.

Eur Respir J. 2016 Mar;47(3):751-68. doi: 10.1183/13993003.01882-2015. Epub 2016 Feb 4.

5.

A systematic review of fractional exhaled nitric oxide in the routine management of childhood asthma.

Gomersal T, Harnan S, Essat M, Tappenden P, Wong R, Lawson R, Pavord I, Everard ML.

Pediatr Pulmonol. 2016 Mar;51(3):316-28. doi: 10.1002/ppul.23371. Epub 2016 Feb 1. Review.

PMID:
26829581
6.

Exhaled Nitric Oxide For The Diagnosis Of Asthma In Adults And Children: A Systematic Review.

Harnan S, Essat M, Gomersall T, Tappenden P, Wong R, Lawson R, Pavord I, Everard M.

Value Health. 2015 Nov;18(7):A345. doi: 10.1016/j.jval.2015.09.607. Epub 2015 Oct 20. No abstract available.

PMID:
26531956
7.

Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath.

Harnan SE, Tappenden P, Essat M, Gomersall T, Minton J, Wong R, Pavord I, Everard M, Lawson R.

Health Technol Assess. 2015 Oct;19(82):1-330. doi: 10.3310/hta19820.

8.

Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Essat M, Tappenden P, Ren S, Bessey A, Archer R, Wong R, Lobo A, Hoque S.

Pharmacoeconomics. 2016 Mar;34(3):245-57. doi: 10.1007/s40273-015-0334-3.

PMID:
26477040
9.

A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.

Campbell F, Holmes M, Everson-Hock E, Davis S, Buckley Woods H, Anokye N, Tappenden P, Kaltenthaler E.

Health Technol Assess. 2015 Jul;19(60):1-110. doi: 10.3310/hta19600.

10.

Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers.

Ciani O, Davis S, Tappenden P, Garside R, Stein K, Cantrell A, Saad ED, Buyse M, Taylor RS.

Int J Technol Assess Health Care. 2014 Jul;30(3):312-24. doi: 10.1017/S0266462314000300.

PMID:
25308694
11.

Dry powder inhalers in cystic fibrosis: same old drugs but different benefits?

Uttley L, Tappenden P.

Curr Opin Pulm Med. 2014 Nov;20(6):607-12. doi: 10.1097/MCP.0000000000000109. Review.

PMID:
25221853
12.

Identification and review of cost-effectiveness model parameters: a qualitative study.

Kaltenthaler E, Essat M, Tappenden P, Paisley S.

Int J Technol Assess Health Care. 2014 Jul;30(3):333-40. doi: 10.1017/S0266462314000245. Epub 2014 Aug 4.

PMID:
25089856
13.

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Latimer NR, Carroll C, Wong R, Tappenden P, Venning MC, Luqmani R.

Pharmacoeconomics. 2014 Dec;32(12):1171-83. doi: 10.1007/s40273-014-0189-z.

14.

Avoiding and identifying errors and other threats to the credibility of health economic models.

Tappenden P, Chilcott JB.

Pharmacoeconomics. 2014 Oct;32(10):967-79. doi: 10.1007/s40273-014-0186-2.

PMID:
25027943
15.

Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme.

Asaria M, Griffin S, Cookson R, Whyte S, Tappenden P.

Health Econ. 2015 Jun;24(6):742-54. doi: 10.1002/hec.3058. Epub 2014 May 2.

PMID:
24798212
16.

The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis.

Tappenden P, Harnan S, Uttley L, Mildred M, Walshaw M, Taylor C, Brownlee K.

Pharmacoeconomics. 2014 Feb;32(2):159-72. doi: 10.1007/s40273-013-0122-x.

PMID:
24338264
17.

Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.

Lord J, Willis S, Eatock J, Tappenden P, Trapero-Bertran M, Miners A, Crossan C, Westby M, Anagnostou A, Taylor S, Mavranezouli I, Wonderling D, Alderson P, Ruiz F.

Health Technol Assess. 2013 Dec;17(58):v-vi, 1-192. doi: 10.3310/hta17580.

18.

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis.

Uttley L, Harnan S, Cantrell A, Taylor C, Walshaw M, Brownlee K, Tappenden P.

Eur Respir Rev. 2013 Dec;22(130):476-86. doi: 10.1183/09059180.00001513. Review.

19.

Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model.

Tappenden P, Harnan S, Uttley L, Mildred M, Carroll C, Cantrell A.

Health Technol Assess. 2013 Dec;17(56):v-xvii, 1-181. doi: 10.3310/hta17560. Review.

20.

A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS).

Rathbone J, Kaltenthaler E, Richards A, Tappenden P, Bessey A, Cantrell A.

BMJ Open. 2013 Nov 4;3(11):e003573. doi: 10.1136/bmjopen-2013-003573.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk